Granulocyte-macrophage colony-stimulating factor enhances 5-lipoxygenase levels in human polymorphonuclear leukocytes - PubMed (original) (raw)
. 1994 Jan 15;152(2):851-8.
Affiliations
- PMID: 8283055
Granulocyte-macrophage colony-stimulating factor enhances 5-lipoxygenase levels in human polymorphonuclear leukocytes
M Pouliot et al. J Immunol. 1994.
Abstract
Stimulation of human polymorphonuclear leukocytes (PMNL) with granulocyte-macrophage CSF (GM-CSF) results in the enhanced expression of several genes, including some coding for cytokines and enzymes. In this study, we investigated the ability of GM-CSF to up-regulate the human neutrophil 5-lipoxygenase (5-LO), a key enzyme in the leukotriene synthetic pathway. GM-CSF induced a dose- and time-dependent de novo synthesis of the 5-LO in PMNL, as determined by immunoprecipitation of 35S-methionine-labeled 5-LO. This up-regulation occurred within 30 min of treatment with GM-CSF and was observed using concentrations of GM-CSF as low as 30 pM. Prior treatment of the cells with the protein synthesis inhibitor cycloheximide abolished this effect of GM-CSF. Western blot analyses demonstrated that levels of 5-LO did not vary over a 6-h period in unstimulated PMNL treated with CX, and that GM-CSF induced a rapid increase in the total cellular level of 5-LO protein; taken together these results indicated a translational effect of GM-CSF on the expression of the 5-LO. However, GM-CSF did not significantly affect the level of 5-LO mRNA in neutrophils, as determined by Northern blot analysis. Furthermore GM-CSF did not alter the stability of 5-LO mRNA, in agreement with a posttranscriptional effect of GM-CSF on 5-LO expression in PMNL. These results show that human PMNL are capable of up-regulating the expression of the 5-LO in response to physiologic activation.
Similar articles
- Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils.
Pouliot M, McDonald PP, Borgeat P, McColl SR. Pouliot M, et al. J Exp Med. 1994 Apr 1;179(4):1225-32. doi: 10.1084/jem.179.4.1225. J Exp Med. 1994. PMID: 8145039 Free PMC article. - Shift from posttranscriptional to predominant transcriptional control of the expression of the GM-CSF gene during activation of human Jurkat cells.
Razanajaona D, Maroc C, Lopez M, Mannoni P, Gabert J. Razanajaona D, et al. Cell Growth Differ. 1992 May;3(5):299-305. Cell Growth Differ. 1992. PMID: 1633112
Cited by
- Targeting the OXE receptor as a potential novel therapy for asthma.
Powell WS, Rokach J. Powell WS, et al. Biochem Pharmacol. 2020 Sep;179:113930. doi: 10.1016/j.bcp.2020.113930. Epub 2020 Mar 30. Biochem Pharmacol. 2020. PMID: 32240653 Free PMC article. Review. - 5-Oxo-ETE and the OXE receptor.
Grant GE, Rokach J, Powell WS. Grant GE, et al. Prostaglandins Other Lipid Mediat. 2009 Sep;89(3-4):98-104. doi: 10.1016/j.prostaglandins.2009.05.002. Epub 2009 May 18. Prostaglandins Other Lipid Mediat. 2009. PMID: 19450703 Free PMC article. Review. - Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils.
Coffey MJ, Phare SM, George S, Peters-Golden M, Kazanjian PH. Coffey MJ, et al. J Clin Invest. 1998 Aug 15;102(4):663-70. doi: 10.1172/JCI2117. J Clin Invest. 1998. PMID: 9710433 Free PMC article. Clinical Trial. - Regulation of expression of the 5-lipoxygenase pathway.
Bigby TD. Bigby TD. Clin Rev Allergy Immunol. 1999 Spring-Summer;17(1-2):43-58. doi: 10.1007/BF02737596. Clin Rev Allergy Immunol. 1999. PMID: 10436858 Review. No abstract available. - GM-CSF priming drives bone marrow-derived macrophages to a pro-inflammatory pattern and downmodulates PGE2 in response to TLR2 ligands.
Sorgi CA, Rose S, Court N, Carlos D, Paula-Silva FW, Assis PA, Frantz FG, Ryffel B, Quesniaux V, Faccioli LH. Sorgi CA, et al. PLoS One. 2012;7(7):e40523. doi: 10.1371/journal.pone.0040523. Epub 2012 Jul 13. PLoS One. 2012. PMID: 22808181 Free PMC article.